Turning Tissue into
Actionable Intelligence
Nucleai is an AI-driven tissue intelligence company helping biopharma teams unlock the full potential of tissue biology to advance drug development.
Combining advanced multimodal image analysis with clinical outcomes correlation, we transform complex tissue data into actionable intelligence that helps pharma understand why therapies work and which patients are most likely to benefit.
From discovery through late clinical development, we partner with biopharma companies to generate tissue-derived evidence that supports more informed drug development decisions.
Why Nucleai?
Deep Tissue Analysis. Connected to Outcomes. Built for Pharma.
Expert-Led, Not Off-the-Shelf
An integrated team of pathologists, biologists, data scientists, and AI experts adapts our models to each program's data and scientific objectives, delivering interpreted tissue intelligence rather than standalone software.
Multimodal Depth & Clinical Outcomes Correlation
Extract structured, reproducible spatial features across H&E, IHC, mIF, and spatial transcriptomics, connecting tissue biology to clinical outcomes to deliver actionable biomarker insights and enable patient selection.
Transparent & Reproducible AI
Every finding is traceable to its source image, enabling scientists and pathologists to review and verify results against the original tissue slide.
Quality & Scale for Pharma
Established analytical workflows and mature quality and information-security systems support reproducible analysis at scale, from discovery through late clinical development, with a path to clinical trial assay and CDx deployment.
Why Nucleai
Built for Pharma.
Proven Across Programs.
Meet the People Behind Nucleai
